Ecor1 Capital 13F annual report

Ecor1 Capital is an investment fund managing more than $3.27 trillion ran by Oleg Nodelman. There are currently 52 companies in Mr. Nodelman’s portfolio. The largest investments include Apellis Pharmaceuticals Inc and Prothena Corp Plc, together worth $684 billion.

Limited to 30 biggest holdings

$3.27 trillion Assets Under Management (AUM)

As of 7th August 2024, Ecor1 Capital’s top holding is 11,607,425 shares of Apellis Pharmaceuticals Inc currently worth over $445 billion and making up 13.6% of the portfolio value. Relative to the number of outstanding shares of Apellis Pharmaceuticals Inc, Ecor1 Capital owns less than approximately 0.1% of the company. In addition, the fund holds 11,584,280 shares of Prothena Corp Plc worth $239 billion. The third-largest holding is Sarepta Therapeutics Inc worth $222 billion and the next is AnaptysBio Inc worth $188 billion, with 7,521,024 shares owned.

Currently, Ecor1 Capital's portfolio is worth at least $3.27 trillion. The total portfolio value may be much higher due to cash assets that are not publicly disclosed such as fixed income, real estate, or cash equivalents.

Careers at Ecor1 Capital

The Ecor1 Capital office and employees reside in San Francisco, California. According to the last 13-F report filed with the SEC, Oleg Nodelman serves as the Manager at Ecor1 Capital.

Recent trades

In the most recent 13F filing, Ecor1 Capital revealed that it had opened a new position in Janux Therapeutics Inc and bought 1,469,818 shares worth $61.6 billion.

The investment fund also strengthened its position in Apellis Pharmaceuticals Inc by buying 250,000 additional shares. This makes their stake in Apellis Pharmaceuticals Inc total 11,607,425 shares worth $445 billion. Apellis Pharmaceuticals Inc soared 5.4% in the past year.

On the other hand, there are companies that Ecor1 Capital is getting rid of from its portfolio. Ecor1 Capital closed its position in Alector on 14th August 2024. It sold the previously owned 4,056,548 shares for $24.4 billion. Oleg Nodelman also disclosed a decreased stake in Sarepta Therapeutics Inc by 0.3%. This leaves the value of the investment at $222 billion and 1,407,322 shares.

One of the largest hedge funds

The two most similar investment funds to Ecor1 Capital are Mutual Advisors and Polar Asset Management Partners. They manage $3.26 trillion and $3.26 trillion respectively.


Oleg Nodelman investment strategy

Ecor1 Capital’s portfolio is diversified across 2 sectors. Currently, their heaviest sector is Health Care — making up 61.9% of the total portfolio value. The fund focuses on investments in the United States as 50.0% of the portfolio companies are based in the United States.

The majority of the companies in the fund’s portfolio are small-cap stocks. Stocks with a size of more than $100 million in market cap make up 6% of the total holdings value. On the other hand, large-cap stocks make up only 1.9% of the portfolio. The average market cap of the portfolio companies is close to $1.81 billion.

The complete list of Ecor1 Capital trades based on 13F SEC filings

These positions were updated on August 14th based on the fund’s latest 13F filing. Quickly find out what the most recently closed or increased positions are.

Security Shares Owned Value Allocation
Apellis Pharmaceuticals Inc
2.20%
11,607,425
$445,260,823,000 13.64%
Prothena Corp Plc
No change
11,584,280
$239,099,539,000 7.32%
Sarepta Therapeutics Inc
26.70%
1,407,322
$222,356,876,000 6.81%
AnaptysBio Inc
No change
7,521,024
$188,476,861,000 5.77%
Crinetics Pharmaceuticals In
No change
4,155,375
$186,119,246,000 5.70%
Arvinas Inc
No change
6,726,491
$179,059,190,000 5.48%
Morphic Hldg Inc
108.98%
4,982,945
$169,768,936,000 5.20%
Galapagos NV
No change
5,756,268
$142,640,321,000 4.37%
Kura Oncology Inc
No change
5,806,871
$119,563,474,000 3.66%
Tango Therapeutics Inc
No change
13,330,736
$114,377,715,000 3.50%
Zymeworks Inc
No change
13,437,473
$114,352,895,000 3.50%
Jazz Pharmaceuticals plc
No change
1,013,952
$108,219,097,000 3.31%
Xencor Inc
No change
5,330,416
$100,904,775,000 3.09%
CRISPR Therapeutics AG
No change
1,389,276
$75,034,797,000 2.30%
Janux Therapeutics Inc
Opened
1,469,818
$61,570,676,000 1.89%
Nuvation Bio Inc
No change
19,209,643
$56,092,158,000 1.72%
Centessa Pharmaceuticals Plc
1.70%
5,714,404
$51,601,068,000 1.58%
iTeos Therapeutics, Inc.
62.55%
3,249,835
$48,227,551,000 1.48%
Immunome, Inc.
No change
3,879,415
$46,940,922,000 1.44%
Neurogene Inc
No change
1,271,342
$46,264,135,000 1.42%
Third Harmonic Bio Inc
No change
3,182,444
$41,371,772,000 1.27%
Mersana Therapeutics Inc
No change
19,364,688
$38,923,023,000 1.19%
Voyager Therapeutics Inc
No change
3,917,546
$30,987,789,000 0.95%
Avidity Biosciences, Inc.
No change
757,576
$30,946,980,000 0.95%
Tscan Therapeutics Inc
No change
5,000,000
$29,250,000,000 0.90%
Adaptimmune Therapeutics Plc
No change
27,404,070
$26,716,228,000 0.82%
Alector, Inc.
Closed
4,056,548
$24,420,419,000
Oric Pharmaceuticals, Inc.
No change
3,418,068
$24,165,741,000 0.74%
Cargo Therapeutics Inc
Opened
1,470,000
$24,137,400,000 0.74%
Celldex Therapeutics Inc.
No change
650,000
$24,056,500,000 0.74%
Vaxcyte, Inc.
No change
300,000
$22,653,000,000 0.69%
Edgewise Therapeutics Inc
No change
1,250,385
$22,519,434,000 0.69%
Acadia Pharmaceuticals Inc
77.53%
1,346,475
$21,880,219,000 0.67%
Nkarta, Inc.
Closed
2,000,000
$21,620,000,000
Lenz Therapeutics Inc
No change
1,219,774
$21,089,892,000 0.65%
Madrigal Pharmaceuticals Inc
No change
75,000
$21,012,000,000 0.64%
Neumora Therapeutics Inc.
No change
2,071,450
$20,362,354,000 0.62%
Ovid Therapeutics Inc
Closed
6,117,400
$18,658,070,000
Bicycle Therapeutics plc
Opened
910,000
$18,418,400,000 0.56%
Atea Pharmaceuticals, Inc.
11.45%
5,441,896
$18,012,676,000 0.55%
Pharvaris N V
No change
900,000
$16,920,000,000 0.52%
Dyne Therapeutics, Inc.
No change
427,039
$15,070,206,000 0.46%
Tectonic Therapeutic Inc
Opened
849,143
$13,985,385,000 0.43%
Rocket Pharmaceuticals Inc
Opened
508,393
$10,945,701,000 0.34%
Gossamer Bio, Inc.
Closed
9,195,404
$10,850,577,000
Keros Therapeutics, Inc.
No change
187,500
$8,568,750,000 0.26%
Kodiak Sciences Inc
Closed
1,613,600
$8,487,536,000
AlloVir, Inc.
No change
11,294,585
$8,169,373,000 0.25%
Replimune Group Inc
Opened
850,341
$7,653,069,000 0.23%
Atara Biotherapeutics Inc
Closed
10,167,043
$7,055,928,000
Verve Therapeutics Inc
No change
1,250,000
$6,100,000,000 0.19%
Generation Bio Co.
No change
2,046,867
$5,772,165,000 0.18%
Arcutis Biotherapeutics Inc
Closed
500,000
$4,955,000,000
Prime Medicine Inc
No change
700,000
$3,598,000,000 0.11%
Atara Biotherapeutics Inc
Opened
406,679
$3,456,772,000 0.11%
Proqr Thrapeutics N V
29.18%
2,042,771
$3,391,000,000 0.10%
Hookipa Pharma Inc
24.42%
5,717,324
$3,383,512,000 0.10%
Kyverna Therapeutics Inc
No change
450,000
$3,375,000,000 0.10%
Aligos Therapeutics, Inc.
No change
6,389,468
$2,236,314,000 0.07%
Pmv Pharmaceuticals Inc
Closed
566,879
$963,694,000
Alpine Immune Sciences Inc
Closed
1,000
$39,640,000
No transactions found
Showing first 500 out of 61 holdings